The Latin America, Middle East and Africa Toxicity Testing Outsourcing Market would witness market growth of 10.6% CAGR during the forecast period (2022-2028).
As biologics address complicated illnesses, there has been a noticeable rise in demand for them. A rise in medical expenditure is also seen throughout the world to assist toxicity testing. The biopharmaceutical industry is making significant investments, working harder to procure better technologies, and exhibiting increased optimism.
Toxicology testing was one of the most often outsourced operations among the 26 domains examined, according to a survey. The complexity of development and research is likewise increasing. Pharmaceutical and biopharmaceutical companies work in contexts that are getting harder to understand.
The development of new therapies such as biologics, genetically targeted therapies, stem cell therapies, as well as other treatment modalities, along with advancements in many therapy categories, have led to more complex regulation and development processes. Toxicology testing is required at every stage of treatment development in order to provide a safe and effective product, which is driving the market's expansion.
The development of structure-based drug designs, increased funding for life sciences research, expanding government and university involvement in proteomics research and genomics, and the growing adoption of cutting-edge technologies all contribute to the rise in share. The Middle Eastern government cites a number of variables for the rise of toxicity testing mechanisms in the region. These variables include strict regulation overseeing product safety evaluations, major research and development budgets, the presence of prominent toxicity testing CROs in the region, and strong consumer understanding regarding product safety.
The Brazil market dominated the LAMEA Toxicity Testing Outsourcing Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $69.5 million by 2028.The Argentina market is experiencing a CAGR of 11.1% during (2022-2028). Additionally, The UAE market would showcase a CAGR of 10.2% during (2022-2028).
Based on End Use, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, Academic & Research Institutes and Others. Based on Method, the market is segmented into In Vitro and In Vivo. Based on GLP, the market is segmented into GLP and Non-GLP. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Eurofins Scientific Group, WuXi AppTec Co., Ltd., SGS S.A., Intertek Group PLC, Catalent, Inc., Laboratory Corporation of America Holdings, Charles River Laboratories International, Inc., ICON PLC, and Medpace Holdings, Inc.
As biologics address complicated illnesses, there has been a noticeable rise in demand for them. A rise in medical expenditure is also seen throughout the world to assist toxicity testing. The biopharmaceutical industry is making significant investments, working harder to procure better technologies, and exhibiting increased optimism.
Toxicology testing was one of the most often outsourced operations among the 26 domains examined, according to a survey. The complexity of development and research is likewise increasing. Pharmaceutical and biopharmaceutical companies work in contexts that are getting harder to understand.
The development of new therapies such as biologics, genetically targeted therapies, stem cell therapies, as well as other treatment modalities, along with advancements in many therapy categories, have led to more complex regulation and development processes. Toxicology testing is required at every stage of treatment development in order to provide a safe and effective product, which is driving the market's expansion.
The development of structure-based drug designs, increased funding for life sciences research, expanding government and university involvement in proteomics research and genomics, and the growing adoption of cutting-edge technologies all contribute to the rise in share. The Middle Eastern government cites a number of variables for the rise of toxicity testing mechanisms in the region. These variables include strict regulation overseeing product safety evaluations, major research and development budgets, the presence of prominent toxicity testing CROs in the region, and strong consumer understanding regarding product safety.
The Brazil market dominated the LAMEA Toxicity Testing Outsourcing Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $69.5 million by 2028.The Argentina market is experiencing a CAGR of 11.1% during (2022-2028). Additionally, The UAE market would showcase a CAGR of 10.2% during (2022-2028).
Based on End Use, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, Academic & Research Institutes and Others. Based on Method, the market is segmented into In Vitro and In Vivo. Based on GLP, the market is segmented into GLP and Non-GLP. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Eurofins Scientific Group, WuXi AppTec Co., Ltd., SGS S.A., Intertek Group PLC, Catalent, Inc., Laboratory Corporation of America Holdings, Charles River Laboratories International, Inc., ICON PLC, and Medpace Holdings, Inc.
Scope of the Study
Market Segments Covered in the Report:
By End Use
- Pharmaceutical & Biopharmaceutical Companies
- Academic & Research Institutes
- Others
By Method
- In Vitro
- In Vivo
By GLP
- GLP
- Non-GLP
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Thermo Fisher Scientific, Inc.
- Eurofins Scientific Group
- WuXi AppTec Co., Ltd.
- SGS S.A.
- Intertek Group PLC
- Catalent, Inc.
- Laboratory Corporation of America Holdings
- Charles River Laboratories International, Inc.
- ICON PLC
- Medpace Holdings, Inc.
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. LAMEA Toxicity Testing Outsourcing Market by End Use
Chapter 4. LAMEA Toxicity Testing Outsourcing Market by Method
Chapter 5. LAMEA Toxicity Testing Outsourcing Market by GLP
Chapter 6. LAMEA Toxicity Testing Outsourcing Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Thermo Fisher Scientific, Inc.
- Eurofins Scientific Group
- WuXi AppTec Co., Ltd.
- SGS S.A.
- Intertek Group PLC
- Catalent, Inc.
- Laboratory Corporation of America Holdings
- Charles River Laboratories International, Inc.
- ICON PLC
- Medpace Holdings, Inc.
Methodology
LOADING...
